BRIEF-Editas Medicine Inc initiates clinical natural history study of Leber Congenital Amaurosis type 10
September 12, 2017 at 09:20 AM EDT
* Editas Medicine Inc - announced that company initiated a clinical natural history study of Leber Congenital Amaurosis type 10 (LCA10)